Bergerot CD - Search Results

1

mHealth program for patients with advanced cancer receiving treatment in a public health hospital in Brazil.

Tumeh IBRG, Bergerot CD, Lee D, Philip EJ, Freitas-Júnior R. Tumeh IBRG, et al. Among authors: bergerot cd. Psychooncology. 2023 Jan;32(1):125-132. doi: 10.1002/pon.6059. Epub 2022 Oct 31. Psychooncology. 2023. PMID: 36284459

2

Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement.

Hall DL, Wagner LI, Lebel S, Smith AB, Bergerot CD, Park ER. Hall DL, et al. Among authors: bergerot cd. Cancer. 2024 Aug 15;130(16):2739-2742. doi: 10.1002/cncr.35326. Epub 2024 Apr 17. Cancer. 2024. PMID: 38630904

3

Construction and validation of clinical contents for development of learning objects.

Hortense FTP, Bergerot CD, Domenico EBL. Hortense FTP, et al. Among authors: bergerot cd. Rev Bras Enferm. 2018 Mar-Apr;71(2):306-313. doi: 10.1590/0034-7167-2016-0622. Rev Bras Enferm. 2018. PMID: 29412287 Free article. English, Portuguese.

4

Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.

Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, Chung JH, Ali SM, Jones JO, Salgia R. Pal SK, et al. Eur Urol. 2018 Jul;74(1):124-128. doi: 10.1016/j.eururo.2018.03.032. Eur Urol. 2018. PMID: 29685646 No abstract available.

5

Adjuvant treatment in renal cell carcinoma.

Dizman N, Adashek JJ, Hsu J, Bergerot PG, Bergerot CD, Pal SK. Dizman N, et al. Among authors: bergerot cd, bergerot pg. Clin Adv Hematol Oncol. 2018 Aug;16(8):555-563. Clin Adv Hematol Oncol. 2018. PMID: 30148828 Review.

6

Distress in patients with renal cell carcinoma: a curious gap in knowledge.

Bergerot CD, Battle D, Staehler MD, Pal SK. Bergerot CD, et al. BJU Int. 2019 Feb;123(2):208-209. doi: 10.1111/bju.14564. Epub 2018 Oct 24. BJU Int. 2019. PMID: 30253048 No abstract available.

7

Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma.

Staehler M, Battle D, Pal SK, Bergerot CD. Staehler M, et al. Among authors: bergerot cd. Eur Urol Focus. 2021 Nov;7(6):1355-1362. doi: 10.1016/j.euf.2020.09.002. Epub 2020 Sep 11. Eur Urol Focus. 2021. PMID: 32943372 Free PMC article.

8

Exceptional Response to Nivolumab Rechallenge in Metastatic Renal Cell Carcinoma with Parallel Changes in Genomic Profile.

Dizman N, Bergerot P, Bergerot C, Lanman RB, Raymond VM, Banks KC, Jones J, Pal SK. Dizman N, et al. Eur Urol. 2018 Feb;73(2):308-310. doi: 10.1016/j.eururo.2017.08.006. Epub 2017 Aug 24. Eur Urol. 2018. PMID: 28844598 No abstract available.

9

COVID-19 and financial toxicity in patients with renal cell carcinoma.

Staehler MD, Battle DJ, Bergerot CD, Pal SK, Penson DF. Staehler MD, et al. Among authors: bergerot cd. World J Urol. 2021 Jul;39(7):2559-2565. doi: 10.1007/s00345-020-03476-6. Epub 2020 Oct 22. World J Urol. 2021. PMID: 33090258 Free PMC article.

10

The Role of Circulating Tumor DNA in Renal Cell Carcinoma.

Bergerot PG, Hahn AW, Bergerot CD, Jones J, Pal SK. Bergerot PG, et al. Among authors: bergerot cd. Curr Treat Options Oncol. 2018 Feb 20;19(2):10. doi: 10.1007/s11864-018-0530-4. Curr Treat Options Oncol. 2018. PMID: 29464405 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters